EUVIMEDEUVIMED entdecken
Open Access

Lifetime water arsenic, genetic susceptibility, and bladder cancer in the New England Bladder Cancer Study

Hugo Pomares-Millan iD, Stella Koutros iD, Dalsu Baris iD, Molly Schwenn, Alison Johnson iD, Nathaniel Rothman, Debra T Silverman, Steven D Leach, Margaret R Karagas, Michael N Passarelli iD

JNCI Cancer Spectrum · 2025

DOI: 10.1093/jncics/pkaf064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2025. Verfasst von Hugo Pomares-Millan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Hanover, Lebanon, NH, United States. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Arsenic, Genetic Predisposition to Disease, Gene-Environment Interaction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIEHS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Exposure to arsenic in drinking water may interact with common genetic variants in urinary bladder cancer risk.

Methods

We conducted a gene-environment interaction analysis among 1091 bladder cancer cases and 928 controls from the New England Bladder Cancer Study. Genetic variants tested as effect modifiers included those associated with bladder cancer and arsenic metabolism. Interactions with disease-specific polygenic scores and a genome-wide gene-environment interaction analysis were also conducted. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimated with average arsenic concentration (µg/L), average daily arsenic (µg/day), and cumulative arsenic (mg) in water as exposures.

Results

Multiplicative interactions for bladder cancer risk were identified for cumulative arsenic and rs1046428 of GSTZ1 on 14q23 (TT and TC genotype: ORT3vsT1 = 1.44, 95% CI = 1.05 to 1.98; Pinteraction= .01) and for average daily arsenic and rs1801133 (C677T) and rs1801131 (A1298C) of MTHFR on 1p36 (TT and TC genotypes: ORT3vsT1 = 1.53, 95% CI = 1.06 to 2.23; Pinteraction= .02; CC and CA genotype: ORT3vsT1 = 1.63, 95% CI = 1.16 to 2.29; Pinteraction=.01, respectively). A global interaction between arsenic exposure and polygenic scores was also observed (ORT3vsT1 = 1.80, 95% CI = 1.26 to 2.56; Pinteraction=. 01). Genome-wide gene-environment interaction analyses suggested interactions with 5 loci with a Pinteraction of no more than 5e-6.

Conclusions

Genetic variants that function in arsenic metabolism involving folate and oxidative stress pathways and a global summary of genetic susceptibility to bladder cancer may modify the association between elevated arsenic exposure from drinking water and bladder cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsArsenicGenetic Predisposition to DiseaseGene-Environment InteractionDrinking WaterWater Pollutants, ChemicalHumansFemaleMaleMiddle AgedCase-Control StudiesAgedNew EnglandPolymorphism, Single NucleotideGenome-Wide Association StudyOdds RatioGlutathione TransferaseMethylenetetrahydrofolate Reductase (NADPH2)

Substanzen

ArsenicDrinking WaterWater Pollutants, ChemicalGlutathione TransferaseMethylenetetrahydrofolate Reductase (NADPH2)

Autor:innen und Institutionen

  • Department of Epidemiology, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Hanover, Lebanon, NH, United States.
  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, US National Institutes of Health, Bethesda, MD, United States.
  • Formerly Maine Cancer Registry, Augusta, ME, United States.
  • Formerly Vermont Department of Health, Burlington, VT, United States.
  • Dartmouth Cancer Center, Dartmouth College, Hanover, NH, United States.

ORCID-Profile: Hugo Pomares-Millan, Stella Koutros, Dalsu Baris, Alison Johnson, Michael N Passarelli

Förderung

  • NIH HHS
  • NIEHS NIH HHS
  • NCI NIH HHS
  • Intramural NIH HHS
  • NIGMS NIH HHS
  • National Institute of General Medical Sciences
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Pomares-Millan, H., Koutros, S., Baris, D., Schwenn, M., Johnson, A., Rothman, N., Silverman, D. T., Leach, S. D., Karagas, M. R., & Passarelli, M. N. (2025). Lifetime water arsenic, genetic susceptibility, and bladder cancer in the New England Bladder Cancer Study. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkaf064

Vancouver

Pomares-Millan H, Koutros S, Baris D, Schwenn M, Johnson A, Rothman N, et al. Lifetime water arsenic, genetic susceptibility, and bladder cancer in the New England Bladder Cancer Study. JNCI Cancer Spectrum. 2025. doi:10.1093/jncics/pkaf064

BibTeX
@article{PomaresMillan2025,
  author = {Pomares-Millan, Hugo and Koutros, Stella and Baris, Dalsu and Schwenn, Molly and Johnson, Alison and Rothman, Nathaniel and Silverman, Debra T and Leach, Steven D and Karagas, Margaret R and Passarelli, Michael N},
  title = {Lifetime water arsenic, genetic susceptibility, and bladder cancer in the New England Bladder Cancer Study},
  journal = {JNCI Cancer Spectrum},
  year = {2025},
  doi = {10.1093/jncics/pkaf064}
}
Kostenlos starten →